The store will not work correctly when cookies are disabled.
2-{[(5-Isopropyl-3-methyl-1-benzothien-2-yl)sulfonyl]amino}-1,3-thiazole-5-carboxylic acid
ID: ALA3731045
PubChem CID: 56942934
Max Phase: Preclinical
Molecular Formula: C16H16N2O4S3
Molecular Weight: 396.51
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1c(S(=O)(=O)Nc2ncc(C(=O)O)s2)sc2ccc(C(C)C)cc12
Standard InChI: InChI=1S/C16H16N2O4S3/c1-8(2)10-4-5-12-11(6-10)9(3)15(23-12)25(21,22)18-16-17-7-13(24-16)14(19)20/h4-8H,1-3H3,(H,17,18)(H,19,20)
Standard InChI Key: VPYGNBKIDNDUGA-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
2.5956 -2.7031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5973 -1.5031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6375 -0.9049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7248 1.2135 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-3.6065 0.0000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7248 -1.2135 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0955 -2.3548 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.1047 0.0000 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-5.7044 -1.0395 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-6.3047 -0.0006 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-5.8559 1.2992 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-7.3568 1.2992 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-8.2191 2.5110 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-9.6447 2.0445 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-9.6416 0.5445 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-8.2141 0.0839 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-10.8501 -0.3411 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-10.7205 -1.5341 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-11.9482 0.1427 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
2 4 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 1 0
9 10 2 0
10 11 1 0
10 12 1 0
12 7 1 0
12 13 2 0
13 4 1 0
9 14 1 0
14 15 2 0
14 16 2 0
14 17 1 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 18 1 0
21 23 1 0
23 24 2 0
23 25 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 396.51 | Molecular Weight (Monoisotopic): 396.0272 | AlogP: 4.29 | #Rotatable Bonds: 5 |
Polar Surface Area: 96.36 | Molecular Species: ACID | HBA: 6 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 3.26 | CX Basic pKa: ┄ | CX LogP: 4.39 | CX LogD: 0.26 |
Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.67 | Np Likeness Score: -1.35 |
References
1. (2012) New compounds, |
2. (2016) Sulfonamide compounds, |